Genomic structure of the human KDR/flk-1 gene

Mammalian Genome

Volumn 9, Issue 5, 1998, Pages 408-410

  Yin, Li Yan ^a   Wu, Yaxu ^a   Ballinger, Carol A ^a   Patterson, Cam ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR;

ARTICLE; DNA SEQUENCE; EXON; GENE MAPPING; GENE STRUCTURE; GENETIC ORGANIZATION; INTRON; NUCLEOTIDE SEQUENCE;

DNA, COMPLEMENTARY; EXONS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 0031862478     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003359900783     Document Type: Article

References (18)

1. Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15, 4919-4927
2. Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70
3. Giebel LB, Strunk KM, Holmes SA, Sprite RA (1992) Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7, 2207-2217
4. Heideran MA, Pierce JH, Jensen RA, Matsui T, Aaronson SA (1990) Chimeric α and β-platelet derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the α-PDGF receptor and determine PDGF-AA binding specificity. J Biol Chem 265, 18741-18744
5. Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T (1995) Structure, organization, and transcription units of the human α-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30, 224-232
6. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88, 9026-9030
7. Patterson C, Perrella MA, Hsieh C-M, Yoshizumi M, Lee M-E, Haber E (1995) Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem 270, 23111-23118
8. Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee M-E, Haber E (1996) Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98, 490-496
9. Patterson C, Wu Y, Lee M-E, DeVault JD, Runge MS, Haber E (1997) Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. J Biol Chem 272, 8410-8416
10. Pepper MS (1997) Manipulating angiogenesis. Circ Res 17, 605-619.
11. Rosnet O, Stephenson D, Mattei M-G, Marchetto S, Shibuya M, Chapman VM, Birnbaum D (1993) Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8, 173-179
12. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman M, Schuh A (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66
13. Shibuya M, Yamaguchi S, Yamane A, lkeda T, Tojo A, Matsushime H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fins family. Oncogene 5, 519-524
14. Spritz RA, Strunk KM, Lee S-T, Lu-kuo JM, Ward DC, le Paslier D, Altherr MR, Dorman TE, Moir DT (1994). A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12, Genomics 22, 431-436
15. Sternberg NL (1992) Cloning high molecular weight DNA fragments by the bacteriophage Pl system. Trends Genet 8, 11-16
16. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-1683
17. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212
18. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181-1190